IL89541A0 - Urethane-protected amino acid-n-carboxyanhydrides and their use in the synthesis of polypeptides - Google Patents
Urethane-protected amino acid-n-carboxyanhydrides and their use in the synthesis of polypeptidesInfo
- Publication number
- IL89541A0 IL89541A0 IL89541A IL8954189A IL89541A0 IL 89541 A0 IL89541 A0 IL 89541A0 IL 89541 A IL89541 A IL 89541A IL 8954189 A IL8954189 A IL 8954189A IL 89541 A0 IL89541 A0 IL 89541A0
- Authority
- IL
- Israel
- Prior art keywords
- urethane
- amino acid
- protected amino
- synthesis
- carboxyanhydrides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/26—Oxygen atoms attached in position 2 with hetero atoms or acyl radicals directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/44—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
- C07K1/023—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution using racemisation inhibiting agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/168,087 US4946942A (en) | 1988-03-11 | 1988-03-11 | Urethane-protected amino acid-N-carboxyanhydrides |
Publications (1)
Publication Number | Publication Date |
---|---|
IL89541A0 true IL89541A0 (en) | 1989-09-10 |
Family
ID=22610066
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL89541A IL89541A0 (en) | 1988-03-11 | 1989-03-08 | Urethane-protected amino acid-n-carboxyanhydrides and their use in the synthesis of polypeptides |
Country Status (21)
Country | Link |
---|---|
US (1) | US4946942A (zh) |
EP (1) | EP0357750B1 (zh) |
JP (1) | JP2875834B2 (zh) |
KR (1) | KR970002229B1 (zh) |
CN (1) | CN1022412C (zh) |
AT (1) | ATE108438T1 (zh) |
AU (1) | AU616054B2 (zh) |
CA (1) | CA1321280C (zh) |
CZ (1) | CZ148989A3 (zh) |
DD (1) | DD280322A5 (zh) |
DE (1) | DE68916722T2 (zh) |
FI (1) | FI102379B (zh) |
HK (1) | HK1007744A1 (zh) |
HU (1) | HU205091B (zh) |
IE (1) | IE65149B1 (zh) |
IL (1) | IL89541A0 (zh) |
NO (1) | NO306304B1 (zh) |
NZ (1) | NZ228282A (zh) |
PT (1) | PT89961B (zh) |
RU (1) | RU2007396C1 (zh) |
WO (1) | WO1989008643A1 (zh) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5006661A (en) * | 1987-06-16 | 1991-04-09 | University Of Cincinnati | Selective stereospecific biologically active beta-lactams |
DE3839379A1 (de) * | 1988-11-22 | 1990-05-23 | Hoechst Ag | Verfahren zur herstellung von tripeptiden |
US6406844B1 (en) | 1989-06-07 | 2002-06-18 | Affymetrix, Inc. | Very large scale immobilized polymer synthesis |
US5424186A (en) | 1989-06-07 | 1995-06-13 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis |
US5547839A (en) | 1989-06-07 | 1996-08-20 | Affymax Technologies N.V. | Sequencing of surface immobilized polymers utilizing microflourescence detection |
US6379895B1 (en) | 1989-06-07 | 2002-04-30 | Affymetrix, Inc. | Photolithographic and other means for manufacturing arrays |
US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
US6309822B1 (en) | 1989-06-07 | 2001-10-30 | Affymetrix, Inc. | Method for comparing copy number of nucleic acid sequences |
US5744101A (en) * | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
US5800992A (en) | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
US6346413B1 (en) | 1989-06-07 | 2002-02-12 | Affymetrix, Inc. | Polymer arrays |
US6551784B2 (en) | 1989-06-07 | 2003-04-22 | Affymetrix Inc | Method of comparing nucleic acid sequences |
US6506558B1 (en) | 1990-03-07 | 2003-01-14 | Affymetrix Inc. | Very large scale immobilized polymer synthesis |
WO1992010588A1 (en) | 1990-12-06 | 1992-06-25 | Affymax Technologies N.V. | Sequencing by hybridization of a target nucleic acid to a matrix of defined oligonucleotides |
US6468740B1 (en) | 1992-11-05 | 2002-10-22 | Affymetrix, Inc. | Cyclic and substituted immobilized molecular synthesis |
TW306932B (zh) * | 1993-08-27 | 1997-06-01 | Holland Sweetener Co | |
US7378236B1 (en) | 1994-06-17 | 2008-05-27 | The Board Of Trustees Of The Leland Stanford Junior University | Method for analyzing gene expression patterns |
US7625697B2 (en) * | 1994-06-17 | 2009-12-01 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for constructing subarrays and subarrays made thereby |
US7323298B1 (en) | 1994-06-17 | 2008-01-29 | The Board Of Trustees Of The Leland Stanford Junior University | Microarray for determining the relative abundances of polynuceotide sequences |
IN184759B (zh) * | 1997-07-22 | 2000-09-23 | Kaneka Corp | |
PL339360A1 (en) | 1998-07-21 | 2000-12-18 | Kaneka Corp | Method of crystallising n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanyl-l-proline maleate |
US6545264B1 (en) | 1998-10-30 | 2003-04-08 | Affymetrix, Inc. | Systems and methods for high performance scanning |
SE0000382D0 (sv) | 2000-02-07 | 2000-02-07 | Astrazeneca Ab | New process |
CN1388804A (zh) * | 2000-07-04 | 2003-01-01 | 三井化学株式会社 | 在氮原子上具有取代基的氨基酸-n-羧基酸酐 |
DE10333368B4 (de) * | 2003-07-23 | 2008-08-28 | Universität Leipzig | Oberflächenfunktionalisiertes Trägermaterial, Verfahren zu dessen Herstellung und dessen Verwendungen |
FR2858976B1 (fr) * | 2003-08-22 | 2006-02-10 | Isochem Sa | Procede d'obtention de n-carboxyanhydrides d'alpha-aminoacides a protection urethane |
WO2006047703A2 (en) * | 2004-10-26 | 2006-05-04 | Sigma-Aldrich Co. | Synthesis of amino acid, n-carboxyanhydrides |
NZ569756A (en) | 2005-12-12 | 2011-07-29 | Allaccem Inc | Methods and systems for preparing antimicrobial films and coatings utilising polycyclic bridged ammonium salts |
NZ579785A (en) | 2007-02-21 | 2012-06-29 | Allaccem Inc | Bridged polycyclic compound based compositions for the inhibition and amelioration of disease |
US20090035816A1 (en) * | 2007-08-02 | 2009-02-05 | Scinopharm Taiwan Ltd. | Process for the preparation of a polypeptide |
US8188068B2 (en) * | 2007-08-10 | 2012-05-29 | Allaccem, Inc. | Bridged polycyclic compound based compositions for coating oral surfaces in pets |
US8153617B2 (en) * | 2007-08-10 | 2012-04-10 | Allaccem, Inc. | Bridged polycyclic compound based compositions for coating oral surfaces in humans |
US8153618B2 (en) * | 2007-08-10 | 2012-04-10 | Allaccem, Inc. | Bridged polycyclic compound based compositions for topical applications for pets |
US20090074833A1 (en) * | 2007-08-17 | 2009-03-19 | Whiteford Jeffery A | Bridged polycyclic compound based compositions for controlling bone resorption |
FR2928372B1 (fr) * | 2008-03-10 | 2010-12-31 | Solvay | Procede de synthese peptidique |
US20100004218A1 (en) * | 2008-06-20 | 2010-01-07 | Whiteford Jeffery A | Bridged polycyclic compound based compositions for renal therapy |
US20100016270A1 (en) * | 2008-06-20 | 2010-01-21 | Whiteford Jeffery A | Bridged polycyclic compound based compositions for controlling cholesterol levels |
JP5833635B2 (ja) * | 2011-03-25 | 2015-12-16 | 日本曹達株式会社 | グルタミン酸ベンジルエステルn−無水カルボン酸の結晶、及びグルタミン酸ベンジルエステルn−無水カルボン酸の結晶化方法。 |
MX2017011820A (es) | 2015-03-17 | 2018-03-15 | Regeneron Pharma | Reactivos de acilacion de aminoacidos y metodos para usar los mismos. |
JP6766432B2 (ja) * | 2016-04-28 | 2020-10-14 | Jsr株式会社 | ポリアミノ酸の製造方法 |
CA3054534A1 (en) * | 2017-03-02 | 2018-09-07 | Glytech, Inc. | Method for manufacturing amino acid polymer |
CN112778236A (zh) * | 2019-11-08 | 2021-05-11 | 华东理工大学 | β、γ-氨基酸N-羧基硫代羰基环内酸酐单体的合成、聚合反应、聚合物制备及其应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1173562A (en) * | 1966-04-25 | 1969-12-10 | Pierrel Spa | Chloramphenicol Ester Salts, the Preparation therof and Compositions Containing them |
US4267344A (en) * | 1972-09-22 | 1981-05-12 | Proteinkemisk Institut. Tilknyttet Akademiet For De Tekniske Videnskaber | N-Substituted N-carboxyanhydrides of α-amino acids and their application in the preparation of peptides |
US4038411A (en) * | 1973-09-25 | 1977-07-26 | Merck & Co., Inc. | Antihypertensive amino acid esters |
US4038282A (en) * | 1975-11-26 | 1977-07-26 | Merck & Co., Inc. | Pyridyl-4-methyl-succinimidocarbonate and process for its preparation |
US4367234A (en) * | 1980-07-28 | 1983-01-04 | Pfizer Inc. | Hypoglycemic 5-substituted oxazolidine-2,4-diones |
-
1988
- 1988-03-11 US US07/168,087 patent/US4946942A/en not_active Expired - Lifetime
-
1989
- 1989-03-03 KR KR1019890702114A patent/KR970002229B1/ko not_active IP Right Cessation
- 1989-03-03 JP JP1503158A patent/JP2875834B2/ja not_active Expired - Fee Related
- 1989-03-03 DE DE68916722T patent/DE68916722T2/de not_active Expired - Lifetime
- 1989-03-03 HU HU891841A patent/HU205091B/hu not_active IP Right Cessation
- 1989-03-03 AU AU41887/89A patent/AU616054B2/en not_active Ceased
- 1989-03-03 AT AT89903412T patent/ATE108438T1/de not_active IP Right Cessation
- 1989-03-03 EP EP89903412A patent/EP0357750B1/en not_active Expired - Lifetime
- 1989-03-03 WO PCT/US1989/000875 patent/WO1989008643A1/en active IP Right Grant
- 1989-03-06 CA CA000592823A patent/CA1321280C/en not_active Expired - Fee Related
- 1989-03-08 IL IL89541A patent/IL89541A0/xx unknown
- 1989-03-09 PT PT89961A patent/PT89961B/pt not_active IP Right Cessation
- 1989-03-09 NZ NZ228282A patent/NZ228282A/xx unknown
- 1989-03-10 CZ CS891489A patent/CZ148989A3/cs unknown
- 1989-03-10 DD DD89326451A patent/DD280322A5/de unknown
- 1989-03-10 IE IE77889A patent/IE65149B1/en not_active IP Right Cessation
- 1989-03-10 CN CN89101333A patent/CN1022412C/zh not_active Expired - Fee Related
- 1989-11-10 NO NO894503A patent/NO306304B1/no not_active IP Right Cessation
- 1989-11-10 FI FI895382A patent/FI102379B/fi active IP Right Grant
- 1989-11-10 RU SU894742483A patent/RU2007396C1/ru not_active IP Right Cessation
-
1998
- 1998-06-26 HK HK98106869A patent/HK1007744A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO1989008643A1 (en) | 1989-09-21 |
CN1022412C (zh) | 1993-10-13 |
JPH02503923A (ja) | 1990-11-15 |
PT89961A (pt) | 1989-11-10 |
DD280322A5 (de) | 1990-07-04 |
JP2875834B2 (ja) | 1999-03-31 |
NZ228282A (en) | 1990-10-26 |
EP0357750B1 (en) | 1994-07-13 |
CN1040793A (zh) | 1990-03-28 |
NO306304B1 (no) | 1999-10-18 |
ATE108438T1 (de) | 1994-07-15 |
FI102379B1 (fi) | 1998-11-30 |
DE68916722T2 (de) | 1994-11-03 |
HK1007744A1 (en) | 1999-04-23 |
NO894503D0 (no) | 1989-11-10 |
EP0357750A1 (en) | 1990-03-14 |
IE890778L (en) | 1989-09-11 |
DE68916722D1 (de) | 1994-08-18 |
HUT52488A (en) | 1990-07-28 |
NO894503L (no) | 1989-11-10 |
CA1321280C (en) | 1993-08-10 |
HU205091B (en) | 1992-03-30 |
AU4188789A (en) | 1989-10-05 |
PT89961B (pt) | 1994-04-29 |
FI102379B (fi) | 1998-11-30 |
AU616054B2 (en) | 1991-10-17 |
KR900700469A (ko) | 1990-08-13 |
RU2007396C1 (ru) | 1994-02-15 |
CZ148989A3 (en) | 1997-11-12 |
HU891841D0 (en) | 1990-04-28 |
US4946942A (en) | 1990-08-07 |
KR970002229B1 (ko) | 1997-02-26 |
IE65149B1 (en) | 1995-10-04 |
FI895382A0 (fi) | 1989-11-10 |
EP0357750A4 (en) | 1991-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL89541A0 (en) | Urethane-protected amino acid-n-carboxyanhydrides and their use in the synthesis of polypeptides | |
ZA915307B (en) | Purification directed cloning of peptides | |
EP0324647A3 (en) | Vector for the expression of fusion proteins and protein immunogens | |
NZ512083A (en) | Methods of increasing lean tissue mass using OB protein compositions | |
IL96043A0 (en) | Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known | |
HUT69169A (en) | T-cell-suppressive peptide fragments of human myelin basic protein (hmbp) and pharmaceutical compositions containing them | |
GB8821785D0 (en) | Peptide compounds | |
HK1006674A1 (en) | Synthetic peptides from streptococcal m protein and vaccines prepared therefrom | |
DE69832299D1 (de) | Einkettigen polypeptiden enthalten troponin i und troponin c | |
DE3561201D1 (en) | Medicaments containing tripeptides | |
DK262986A (da) | Peptidmateriale med thymushumoral aktivitet | |
AU2676399A (en) | Novel cystine knot protein and materials and methods for making it | |
YU219289A (en) | Recombinant hybride proteins of interleucine-2 | |
ATE92078T1 (de) | Pharmakologisch aktive peptide. | |
EP0723016A3 (en) | Leukocyte activation factor | |
GB9025320D0 (en) | N-terminal modification of proteins | |
NZ228194A (en) | Monoclonal antibodies which bind to the n-terminal peptide sequence of the betasubunit of human haemoglobiin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed |